Search
From early discovery through QC to monitoring the efficacy, safety, and potency of advanced therapeutics, genetic analysis technologies underpin every stage of therapy development. By enabling precise target selection, real-time assessment of gene expression, and longitudinal monitoring of treatment response, these tools inform better study design and decision-making. Advanced gene expression and biomarker profiling support predictive efficacy readouts and refined patient stratification, helping teams focus resources where they matter most. Thermo Fisher Scientific can support you across the entire pipeline—delivering integrated, innovative genetic analysis solutions that can accelerate timelines, mitigate development risk, and increase therapeutic precision.
Real-time PCR (qPCR)
qPCR is the gold standard for nucleic acid detection that accurately enables you to monitor and quantify gene expression in engineered cells or within clinical trials for biomarker identification.
Digital PCR (dPCR)
Overcome challenges for the detection and quantitation of rare sequences within assays such as vector copy number variation, minimal residual disease, and detection of replication competent virus.
Sanger sequencing
Sanger sequencing provides the accuracy, workflow simplicity, and reproducibility to verify/QC your vector construct and sequence in question and authenticate cell lines.
Assays and master mixes
With over two million pre-designed TaqMan assays enabling reliable quantification of nucleic acids across various applications, simplify your workflow and streamline your data accuracy and reproducibility.
Sample prep
Automated extraction systems with optimized protocols can carry out the tedious wash, bind, and elution steps, handle mixes and separations with minimal oversight, getting samples ready for downstream applications.